They improve health, extend lives, and offer hope where diets and exercise alone have failed
Importantly , the therapeutic selectivity of GLP-1 agonists arises from their specific receptor binding profile, which distinguishes them from other incretin-based therapies
At 5 g per day combined with resistance training, it is associated with an increase in lean body mass of roughly 1.1 kg on average, and about 1.32 kg in older adults, with a strong safety record, though the average masks a meaningful difference between subgroups [1]
Through a blend of medical innovation and lifestyle commitment, many individuals may find a viable path toward healthier, lasting weight management
Benatar M, Wiendl H, Nowak R, Zheng Y, Macias W
doi: 10.3390/ijms24010107 119 KumarDKChoiSHWashicoskyKJEimerWATuckerSGhofraniJet al